Clinical Determinants, Patterns, and Outcomes of Antipsychotic Medication Prescribing in the Treatment of Schizophrenia and Schizoaffective Disorder: A Naturalistic Cohort Study

被引：0
|
作者：
Groenendaal, Emily [1 ]
Lynch, Sean [2 ]
Dornbush, Rhea [1 ]
Klepacz, Lidia [1 ]
Ferrando, Stephen [1 ]
机构：
[1] New York Med Coll, Valhalla, NY USA
[2] Mt Sinai Beth Israel, New York, NY USA
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923001487
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：226 / 227
页数：2
相关论文
共 50 条
  • [41] Antipsychotic response in delusional disorder and schizophrenia: a prospective cohort study
    Gonzalez-Rodriguez, Alexandre
    Catalan, Rosa
    Penades, Rafael
    Ruiz, Victoria
    Torra, Merce
    Bernardo, Miquel
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2016, 44 (04): : 125 - 135
  • [42] The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: A randomized controlled trial
    Constantine, Robert J.
    Andel, Ross
    McPherson, Marie
    Tandon, Rajiv
    SCHIZOPHRENIA RESEARCH, 2015, 166 (1-3) : 194 - 200
  • [43] Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of its reliability and predictive validity
    Nakonezny, Paul A.
    Byerly, Matthew J.
    Rush, A. John
    PSYCHIATRY RESEARCH, 2008, 157 (1-3) : 259 - 263
  • [44] Cocaine Use in Schizophrenia and Schizoaffective Disorder Patients is Associated with Lower Doses of Antipsychotic Medication at the Time of Discharge from Hospital
    Mohite, Satyajit
    Ngana, Ikenna
    Burns, Wilma
    Okusaga, Olaoluwa
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 265S - 265S
  • [45] Antipsychotic efficacy of polypharmacy vs. monotherapy in patients with schizophrenia and schizoaffective disorder: A prospective study
    Lindenmayer, J.
    Khan, A.
    Kaushik, S.
    Iskander, A.
    Kaushik, S.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 442 - 442
  • [46] All-cause medication discontinuation and clinical outcomes in a 12-month naturalistic study of patients with schizophrenia at risk of treatment nonadherence
    Kelin, K.
    Newton, R.
    Lambert, T. J. R.
    Don, L.
    Chen, K. -P.
    Escamilla, R. I.
    Granger, R. E.
    Ye, W.
    Brnabic, A. J. M.
    Montgomery, W.
    Karagianis, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 223 - 224
  • [47] Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia
    Petrakis, IL
    Leslie, D
    Finney, JW
    Rosenheck, R
    AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (01): : 44 - 49
  • [48] ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER
    Verzosa, Natasha
    Williams, Hilary
    Rafizadeh, Reza
    Narang, Ankita
    Carrion, Prescilla
    Procyshyn, Ric
    White, Randall
    Poirier-Morency, Guillaume
    Rogic, Sanja
    Mungall, Andrew
    Sullivan, Patrick
    Honer, William
    Pavlidis, Paul
    Stowe, Robert
    Bousman, Chad
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 63 : E153 - E154
  • [49] Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
    Keating, Dolores
    McWilliams, Stephen
    Boland, Fiona
    Doyle, Roisin
    Behan, Caragh
    Strawbridge, Judith
    Clarke, Mary
    BMJ OPEN, 2021, 11 (01):
  • [50] BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis
    Huang, Eric
    Hettige, Nuwan C.
    Zai, Gwyneth
    Tomasi, Julia
    Huang, Justin
    Zai, Clement C.
    Pivac, Nela
    Perkovic, Matea Nikolac
    Tiwari, Arun K.
    Kennedy, James L.
    PHARMACOGENOMICS JOURNAL, 2019, 19 (03): : 269 - 276
12345